FLORHAM PARK, N.J., July 02, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery…
Curated SPACs News
FLORHAM PARK, N.J., July 02, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery…